NuSynth Technologies raises Rs 36.5 crore in seed funding co-led by Avaana Capital and Shastra VC

AI-driven R&D driving industrial growth

Bengaluru-based deeptech startup NuSynth Technologies has raised Rs 36.5 crore ($4 million) in a seed funding round co-led by Avaana Capital and Shastra VC. The investment round also saw participation from seven to eight angel investors.

The capital injection will support NuSynth as it strengthens its research infrastructure, expands its scientific team, and develops proprietary chemical synthesis routes. Operating an active R&D laboratory and pilot plant in Mysuru, the company is also constructing a new research facility in Bengaluru to accelerate its technology development.

NuSynth’s platform integrates predictive synthesis models with an artificial intelligence engine to reimagine complex chemical production. By converting experimental data into a proprietary knowledge base, the technology shortens R&D cycles, reduces material costs, and replaces hazardous, solvent-heavy processes with safer catalytic and water-based alternatives.

Reducing import dependencies in key sectors

While India has built world-class chemical manufacturing capacity, domestic industries remain reliant on overseas suppliers for several critical chemical intermediates, particularly key building blocks for active pharmaceutical ingredients. NuSynth is working to bridge this critical gap by engineering alternative chemical pathways locally.

Initially focusing on active pharmaceutical ingredients and electronics chemicals, the company plans to broaden its processes to serve nutraceuticals, flavours, and fragrances. Co-founder Poorvank Purohit, former managing director and CEO of Solara Active Pharma Sciences, established the startup alongside Dr Ramesha A R, Abhishek Deo, and Dipak Bajaj.

"At NuSynth, we are going back to first principles—questioning established routes, redesigning processes, and engineering them for commercial scale from day one," Purohit said. "Our ambition is to build proprietary processes from India that can deliver superior economics and sustainability, and serve customers across global markets."

NuSynth works through an asset-light manufacturing model, partnering with more than 20 Indian manufacturing firms to bring laboratory breakthroughs into full-scale production. The startup is currently working on four to five core molecules and expects to commence commercialisation in the second half of 2027 following sampling and customer validation.

Surge in Indian deeptech investments

The funding highlights robust investor momentum in India's technology and industrial innovation ecosystem, where domestic R&D startups are increasingly replacing traditional manufacturing models with high-value intellectual property.

Funding across the Indian deeptech landscape surged by 176 per cent year-on-year in the third quarter of 2026, substantially outperforming the broader startup sector. NuSynth joins a growing cohort of Indian deeptech innovators building sustainable, scalable technology platforms to drive national industrial resilience and global competitiveness.